U.S. regulators on Wednesday approved the first drug for the treatment of Ebola. The Food and Drug Administration gave the greenlight to the drug, developed by Regeneron Pharmaceuticals for treating adults and children with the Zaire Ebola virus strain, the most deadly of six known types. It typically kills 60% to 90% of patients.

Video Transcript

[MUSIC PLAYING]
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Coronavirus Q&A, 15 things to know about COVID-19′s spread – MLive.com

As the new coronavirus claimed its first U.S. victim this weekend amid…

Coronavirus Latest: Cleaner on Bullet Train With Covid-19 May Have Exposed People on a Dozen Trains – Caixin Global

China is grappling with an outbreak of infections from a new coronavirus…